Jiangxi Fushine Pharmaceutical 대차 대조표 상태
재무 상태 기준 확인 3/6
Jiangxi Fushine Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 67.8%. Its total assets and total liabilities are CN¥4.6B and CN¥2.3B respectively.
주요 정보
67.8%
부채 비율
CN¥1.62b
부채
| 이자 보상 비율 | n/a |
| 현금 | CN¥676.89m |
| 주식 | CN¥2.39b |
| 총 부채 | CN¥2.26b |
| 총 자산 | CN¥4.65b |
최근 재무 상태 업데이트
Recent updates
There's Reason For Concern Over Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Massive 28% Price Jump
Oct 04
Is Jiangxi Fushine Pharmaceutical (SZSE:300497) A Risky Investment?
Jun 12What Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) 26% Share Price Gain Is Not Telling You
May 06Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Business And Shares Still Trailing The Industry
Feb 27재무 상태 분석
단기부채: 300497's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.5B).
장기 부채: 300497's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥808.9M).
부채 대 자본 내역 및 분석
부채 수준: 300497's net debt to equity ratio (39.4%) is considered satisfactory.
부채 감소: 300497's debt to equity ratio has increased from 60.8% to 67.8% over the past 5 years.
부채 범위: 300497's debt is not well covered by operating cash flow (6.3%).
이자 보장: Insufficient data to determine if 300497's interest payments on its debt are well covered by EBIT.